China Pharma Holdings (CPHI) Other Non-Current Assets (2010 - 2020)
China Pharma Holdings (CPHI) reported Other Non-Current Assets of $222996.0 for Q2 2020, down 55.69% on a YoY basis from $503312.0 in Q3 2019, and down 32.64% quarter-over-quarter from $331038.0 in Q1 2020.
China Pharma Holdings (CPHI) Other Non-Current Assets (2010 - 2020) Analysis & Trends
China Pharma Holdings has reported Other Non-Current Assets for 8 years, with the latest figure at $222996.0 in Q2 2020.
- For the quarter ending Q2 2020, Other Non-Current Assets fell 55.69% year-over-year to $222996.0; the trailing twelve-month figure through Jun 2020 stood at $222996.0 (down 55.69% YoY), and the FY2019 full-year result was $109908.0, down 91.37% from the prior year.
- Other Non-Current Assets for Q2 2020 stood at $222996.0, down from $331038.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $2.6 million in Q2 2017, with the low at $109908.0 in Q4 2019.
- Historically, Other Non-Current Assets has averaged $1.1 million across 5 years, with a median of $1.2 million in 2018.
- Annual changes were most pronounced in 2017 — Other Non-Current Assets jumped 104.92% — and 2019, when it sank 91.37%.
- China Pharma Holdings' Other Non-Current Assets stood at $1.1 million in 2016, then slumped by 34.81% to $709796.0 in 2017, then jumped by 79.48% to $1.3 million in 2018, then slumped by 91.37% to $109908.0 in 2019, then soared by 102.89% to $222996.0 in 2020.
- The last three Other Non-Current Assets figures came in at $222996.0 (Q2 2020), $331038.0 (Q1 2020), and $109908.0 (Q4 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | China Pharma Holdings | 18.87 Mn | 18.70 Mn | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 222,996.00 |
| Mar 31, 2020 | 331,038.00 |
| Dec 31, 2019 | 109,908.00 |
| Sep 30, 2019 | 489,208.00 |
| Jun 30, 2019 | 503,312.00 |
| Mar 31, 2019 | 976,622.00 |
| Dec 31, 2018 | 1.27 Mn |
| Sep 30, 2018 | 1.48 Mn |
| Jun 30, 2018 | 1.63 Mn |
| Mar 31, 2018 | 1.18 Mn |
| Dec 31, 2017 | 709,796.00 |
| Sep 30, 2017 | 1.38 Mn |
| Jun 30, 2017 | 2.57 Mn |
| Mar 31, 2017 | 1.72 Mn |
| Dec 31, 2016 | 1.09 Mn |
| Sep 30, 2016 | 1.47 Mn |
| Jun 30, 2016 | 1.25 Mn |
| Sep 30, 2012 | 1.19 Mn |
| Jun 30, 2012 | 171,516.00 |
| Mar 31, 2012 | 171,402.00 |